GSK’s Arexvy vaccine for RSV is approved for Malaysian seniors
GlaxoSmithKline (GSK) announced that Arexvy (MAL24086007ARZ) has been approved in Malaysia for RSV (respiratory syncytial virus). The RSV vaccine has …
GlaxoSmithKline (GSK) announced that Arexvy (MAL24086007ARZ) has been approved in Malaysia for RSV (respiratory syncytial virus). The RSV vaccine has …
If you’re 50 and above or someone at higher risk due to a weakened immune system, there’s some exciting news …
Cilisos Media Sdn. Bhd. [201401011719 (1087796-H)] Copyright © 2020. All Rights Reserved